You can be aware of the latest KPC and other carbapenemases news on a daily basis. Every day there are up to 10-15 KPC news stories. We sort them, weed out the duplicates and then create two things. A free daily newsletter, and our Twitter feed. Save yourself hours and be informed in ways that will practically help you, whether you are a patient or a health care worker. See the latest news below and scroll down for a guide to where we get it from and why you can trust it.
- Universal Presence of blaNDM-1 Gene in Carbapenem-Resistant Gram-Negative Bacilli in an Indian Hospital in 2015.
- Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from China CRE Network.
- Deep Interviews with Game Changers of Infection Prevention (Part 1) - www.IC.tips
- Healthcare associated bloodstream infections in Polish hospitals: prevalence, epidemiology and microbiology—summary data from the ECDC Point Prevalence Survey of Healthcare Associated Infections 2012–2015 | SpringerLink
- Eurosurveillance | Analysis of OXA-204 carbapenemase-producing Enterobacteriaceae reveals possible endoscopy-associated transmission, France, 2012 to 2014
- Quantifying Hospital-Acquired Carriage of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Among Patients in Dutch Hospitals | Infection Control & Hospital Epidemiology | Cambridge Core
- CPE guidelines galore: ECDC and ACSQH join the party | Reflections on Infection Prevention and Control
- 30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study | Antimicrobial Resistance & Infection Control | Full Text
- One new case of CPE superbug being detected every day
- Detection of blaCTX-M Extended Spectrum Beta-lactamase Producing Salmonella enterica Serotype Typhi in a Tertiary Care Centre. - PubMed - NCBI
- Successful Management of Urosepsis with Ceftriaxone+Sulbactam+EDTA: A Case Report of Penem Sparing Approach. - PubMed - NCBI
- Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection | bioRxiv
- Clinical effect of discordance in empirical treatment of cases with urinary tract infection accompanied by bacteremia.
- Antibiotic resistance status and its costs in hematological patients: A two-year analysis.
- Characterization of Metagenomes in Urban Aquatic Compartments Reveals High Prevalence of Clinically Relevant Antibiotic Resistance Genes in Wastewaters.
- Update on fosfomycin-modified genes in Enterobacteriaceae. - PubMed - NCBI
- Klebsiella pneumoniae co-producing KPC and RmtG, finally targeting Switzerland. - PubMed - NCBI
- The prevalence and drug resistance pattern of extended spectrum β-lactamases (ESBLs) producing Enterobacteriaceae in Africa.
- Simultaneous isolation of Chryseobacterium gleum from bloodstream and respiratory tract: first case report from India.
- [Giant lithiasis due to urinary stasis related to ileo-caecal bladder].
Visit our specialist pages for further KPC insights
- KPC News – Daily Updates
- How is the KPC superbug treated
- What are KPC superbug symptoms
- What is Klebsiella Pneumonia?
- What is the KPC superbug?
KPC News – Medical Journals
We monitor medical journals for the latest research on issues surrounding KPC and CRE. We pay particular attention to items about transmission, treatment, key drugs and infection control. With over 1000 relevant journal articles being released every year, our service can help you see the latest research headlines at a glance.
KPC News – Twitter
We discover cutting edge analysis via the Twitter accounts of leading infection control specialists, medical journalists and national and international agencies. These unique voices are at the heart of the science surrounding KPC and CRE and the discussions about key trends and best practice.
KPC – Mainstream media
Newspapers all over the world carry KPC and CRE related news. We monitor this using news alert software and add key stories to our news feed as well as removing the many duplicates of the same story that sometimes appear. The media shape popular perceptions of the extent and impact of KPC and CRE. Our KPC news service helps you discover, in 2 minutes a day, the important stories that you might want to explore further.
The newsletter and Twitter feed we offer are unique. We believe they will be helpful to infection control specialists, general nursing staff, patient advocates, medical equipment manufacturers and those working on KPC related drug projects. They are both free. Sponsors for the newsletter are welcome – you can find more information by emailing dave(at)tahilla.com